Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Clene (CLNN) EBIT (2020 - 2025)

Clene has reported EBIT over the past 6 years, most recently at -$7.5 million for Q4 2025.

  • For Q4 2025, EBIT fell 146.47% year-over-year to -$7.5 million; the TTM value through Dec 2025 reached -$23.1 million, down 179.71%, while the annual FY2025 figure was -$23.1 million, 179.12% down from the prior year.
  • EBIT for Q4 2025 was -$7.5 million at Clene, down from -$5.6 million in the prior quarter.
  • Over five years, EBIT peaked at $20.2 million in Q4 2023 and troughed at -$14.1 million in Q4 2021.
  • A 5-year average of -$7.0 million and a median of -$9.7 million in 2022 define the central range for EBIT.
  • Biggest five-year swings in EBIT: plummeted 236.6% in 2021 and later soared 272.88% in 2023.
  • Year by year, EBIT stood at -$14.1 million in 2021, then grew by 16.77% to -$11.7 million in 2022, then soared by 272.88% to $20.2 million in 2023, then decreased by 20.26% to $16.1 million in 2024, then plummeted by 146.47% to -$7.5 million in 2025.
  • Business Quant data shows EBIT for CLNN at -$7.5 million in Q4 2025, -$5.6 million in Q3 2025, and -$5.9 million in Q2 2025.